MUSCATELLO, Maria Rosaria Anna
 Distribuzione geografica
Continente #
NA - Nord America 10.615
EU - Europa 9.827
AS - Asia 5.933
SA - Sud America 2.349
AF - Africa 177
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 11
Totale 28.944
Nazione #
US - Stati Uniti d'America 10.387
IT - Italia 2.697
SG - Singapore 2.501
BR - Brasile 2.063
IE - Irlanda 1.988
SE - Svezia 1.710
CN - Cina 1.662
HK - Hong Kong 778
DE - Germania 756
UA - Ucraina 470
PL - Polonia 438
FI - Finlandia 391
FR - Francia 364
VN - Vietnam 306
GB - Regno Unito 299
RU - Federazione Russa 275
IN - India 138
CA - Canada 97
AR - Argentina 91
MX - Messico 87
NL - Olanda 77
TR - Turchia 74
ES - Italia 67
BD - Bangladesh 63
AT - Austria 60
BE - Belgio 56
JP - Giappone 50
EC - Ecuador 49
ID - Indonesia 49
IQ - Iraq 49
ZA - Sudafrica 41
UZ - Uzbekistan 39
CZ - Repubblica Ceca 37
EG - Egitto 37
MA - Marocco 32
CO - Colombia 30
PK - Pakistan 28
PE - Perù 26
VE - Venezuela 26
AU - Australia 25
PH - Filippine 24
CH - Svizzera 23
PY - Paraguay 23
CL - Cile 22
LT - Lituania 20
AZ - Azerbaigian 18
AE - Emirati Arabi Uniti 16
CI - Costa d'Avorio 14
KE - Kenya 14
NP - Nepal 14
PT - Portogallo 14
JO - Giordania 13
BY - Bielorussia 12
IL - Israele 12
TN - Tunisia 12
DZ - Algeria 11
GR - Grecia 11
KZ - Kazakistan 11
BG - Bulgaria 9
DO - Repubblica Dominicana 9
GE - Georgia 9
IR - Iran 9
LV - Lettonia 9
UY - Uruguay 9
AL - Albania 8
KG - Kirghizistan 8
PA - Panama 8
NZ - Nuova Zelanda 7
OM - Oman 7
RO - Romania 7
BO - Bolivia 6
HR - Croazia 6
JM - Giamaica 6
MY - Malesia 6
SN - Senegal 6
AM - Armenia 5
BN - Brunei Darussalam 5
CR - Costa Rica 5
EU - Europa 5
KR - Corea 5
LB - Libano 5
SI - Slovenia 5
BH - Bahrain 4
HN - Honduras 4
LK - Sri Lanka 4
NO - Norvegia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GY - Guiana 3
MN - Mongolia 3
NG - Nigeria 3
NI - Nicaragua 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
BB - Barbados 2
CG - Congo 2
EE - Estonia 2
GT - Guatemala 2
KH - Cambogia 2
Totale 28.914
Città #
Dublin 1.987
Chandler 1.346
Dallas 1.300
Singapore 1.229
Ashburn 1.165
Jacksonville 979
Nyköping 868
Hong Kong 769
Beijing 749
Warsaw 419
Princeton 292
Los Angeles 286
Medford 281
Messina 251
Dearborn 249
Cambridge 240
Rome 230
The Dalles 228
Des Moines 218
Munich 192
New York 178
Boardman 174
Ann Arbor 172
São Paulo 161
Milan 144
Bremen 140
Buffalo 128
Redondo Beach 104
Turku 97
Ho Chi Minh City 90
Houston 89
Catania 83
Jinan 80
Moscow 77
Rio de Janeiro 66
Wilmington 66
Hanoi 63
Tianjin 63
Shenyang 62
Lancaster 61
Belo Horizonte 58
Brussels 53
Frankfurt am Main 52
Woodbridge 49
Strasbourg 48
Helsinki 47
Turin 47
Hebei 46
Hyderabad 45
San Mateo 45
Vienna 45
Brasília 43
Seattle 43
Nanjing 42
Tokyo 40
Naples 39
Brooklyn 38
Tashkent 38
Pune 36
London 35
Padova 35
Palermo 35
Santa Clara 35
Bari 33
Dong Ket 33
Stockholm 33
Guangzhou 31
San Francisco 31
Ningbo 30
Udine 30
Zhengzhou 29
Cairo 28
Chicago 28
Jakarta 28
Porto Alegre 28
Curitiba 27
Montreal 27
Denver 26
Phoenix 26
Haikou 25
Hangzhou 25
Istanbul 25
Taizhou 25
Amsterdam 24
Campinas 24
Johannesburg 24
Mexico City 24
Washington 24
Chennai 23
Manaus 23
Manchester 23
Nanchang 23
Düsseldorf 22
Genoa 22
Poplar 22
Toronto 22
Atlanta 20
Goiânia 20
Verona 20
Boston 19
Totale 17.317
Nome #
State-Trait Anger Expression Inventory (STAXI) e Defense Mechanisms Inventory (DMI): i limiti di un questionario di autovalutazione 405
Alessitimia, emozioni negative e comportamento sessuale 391
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 355
Fattori di vulnerabilità psicosociale nella depressione postpartum 290
Fear and anxiety managing methods during dental treatments: a systematic review of recent data 231
Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis 199
Il Burnout e l'emozione rabbia. 195
Trattamento con agomelatina in soggetti affetti da fibromialgia: effetti sulla fenomenica depressiva, ansiosa e algica 180
Frazione polifenolica del bergamotto per il trattamento della sindrome metabolica nella schizofrenia: uno studio pilota [Bergamot polyphenolic fraction for the treatment of metabolic syndrome in schizophrenia: A pilot study] 180
JUVENILE CRIMINALITY AND EXECUTIVE COGNITIVE FUNCTIONING IN AN ITALIAN SAMPLE OF LATE-ONSET ADOLESCENT DELINQUENTS 178
Anger in women treated with assisted reproductive technology (ART): effects on mother and newborn 176
Carcinoma mammario e disturbo depressivo. 168
Depressione e disturbi endocrini 167
Alessitimia, internet addiction disorder e mobile addiction in un campione di adolescenti 163
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia. 162
Indagine statistico-epidemiologica per l’analisi dei rischi dipsicopatologia in giovani affetti da diabete mellito di tipo 1 157
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 157
Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders. 156
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 155
Valutazione dell’umore e della personalità in un campione di forti fumatori 150
Affective temperament traits and age-predicted recreational cannabis use in medical students: A cross-sectional study 148
Association between burnout and anger in oncology versus opthalmology health care professionals 147
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 146
Adolescenti: rabbia, sofferenza psicosomatica e tempo libero. 144
Academic stress disrupts cortical plasticity in graduate students 142
The inner muses: How affective temperament traits, gender and age predict film genre preference 142
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 141
Augmentation con Aripiprazolo vs. placebo nel disturbo ossessivo compulsivo con sintomatologia residua in trattamento stabilizzato con SSRI 140
Anger and ego-defence mechanisms in non-psychiatric patients with irritable bowel syndrome 139
CORRELATION ANALYSIS BETWEEN PERSONALITY AND RESILIENCE IN NON CLINICAL SUBJECTS. 139
Reboxetine add-on to clozapine in treatment of negative symptoms of schizophrenia: a preliminary open-label study 138
Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study 137
Extrasensory perception experiences and childhood trauma: A rorschach investigation 137
Defense mechanisms in hemodialysis-dependent patients 135
Alexithymia, Negative Emotions, and Sexual Behavior in Heterosexual University Students from Italy 135
Morphometrical and morphological analysis of lateral ventricles in schizophrenia patients versus healthy controls. 134
Exploring the effect of adaptogenic Rhodiola Rosea extract on neuroplasticity in humans 134
Adult attention deficit/ hyperactivity disorder and borderline personality disorder 133
Depression, anxiety and anger in subtypes of irritable bowel syndrome patients 132
Anger, Smoking Behavior, and the Mediator Effects of Gender: An Investigation of Heavy and Moderate Smokers. 132
Psychopharmacotherapy in pregnancy and breastfeeding 131
Comportamento sessuale ed immaginario erotico in donne tossicodipendenti. 130
Anger and Adolescence: A Psychometric Investigation on a Sample of Italian High School Students 130
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 130
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study 129
STRESS LAVORO CORRELATO NEI MEDICI DI CONTINUITÀ ASSISTENZIALE. 129
Grief and the new DSM-5 clinical category: A narrative review of the literature. 127
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 126
Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. 124
Anger in health, benign breast disease and breast cancer: a prospective case-control study. 124
Funzioni neuropsicologiche e dimensioni psicopatologiche (positiva, negativa e disorganizzata) della schizofrenia. 123
Comparation of levels of anxiety and depression in patients with autommune and chronic-degenerative rheumatic: preliminary data 123
Cannabis and Sexual Behavior 123
Neurobiological and Psychopathological mechanisms underlying addiction-like behaviors: an overview and thematic synthesis 122
SUBTHRESHOLD PSYCHIATRIC SYMPTOMS AND POST-PARTUM MOOD DISORDERS 121
Sleep Quality, Perceived Stress, and Caffeinated Drinks Intake in Psychiatry Residents: A Cross-Sectional Study 121
The wounds of childhood: Early trauma subtypes, salience and hyperarousal in a sample of adult psychiatric patients 119
IL-33 in Mental Disorders 119
Temperamento e alessitimia in un campione di soggetti antisociali con condotte di abuso. 118
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 118
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 118
“Comment on: Psychopathology and female detention at the “Pagliarelli” jail of Palermo: preliminary results.” 118
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 118
Adolescence, Adulthood and Self-Perceived Halitosis: A Role of Psychological Factors 118
Correlation Between Anger and Burnout in the Oncology Staff. 116
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 116
The relationship between sexual behavior and internet addiction severity in a sample of heterosexual university students from Italy. 116
Metabolic outcomes of Red yeast rice administration in patients treated with second-generation antipsychotics 115
Psycho-Neuro-Endocrine-Immune System (PNEI) Involvement as Prognostic Marker in Breast Cancer Patients at 10 Years of Follow Up 114
Inside-out: the role of anger experience and expression in the development of postpartum mood disorders 114
Donepezil adjunctive treatment to clozapine for cognitive impairment in schizophrenia 113
Executive functions and basic symptoms in adolescent antisocial behavior: A cross-sectional study on an Italian sample of late-onset offenders. 113
The role of alexithymia factors in adults with autism spectrum disorder: An explorative study 113
Personality traits predict a medical student preference to pursue a career in surgery 112
Personality traits and emotional patterns in irritable bowel Syndrome 112
Esplorazione neuropsicologica del lobo prefrontale nel disturbo schizofrenico 111
Interazione farmacocinetica tra mirtazapina e clozapina in pazienti schizofrenici. 111
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 111
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder. 111
Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia 111
LA VULNERABILITA' ALL'ESPERIENZA DEL TRAGICO 110
Emotional profiles and psychopathology in severely obese patients: a psychological preoperative evaluation in bariatric surgery 110
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 109
Complicated grief: A systematic review of the last 20 years 108
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 108
Meccanismi di difesa in soggetti sottoposti a trattamento dialitico cronico 107
Attentional and mnestic resistance to interference and the positive, negative and disorganization dimensions of schizophrenia: a correlation study 107
Antisocial personality disorder and subthresold symptomatology 107
Effetto di un trattamento con agomelatina sulle funzioni cognitive/esecutive di un campione di soggetti affetti da fibromialgia 107
Does personality matter? Temperament and character dimensions in panic subtypes 107
Effetti comportamentali dell‘assunzione di L-Dopa in volontari sani. 106
Aripiprazole Plus Topiramate in Opioid-dependent Patients with Schizoaffective Disorder: An 8-week, Open-label, Uncontrolled, Preliminary Study 106
Meccanismi di difesa (D.M.I.) e temperamento (T.C.I.): studio di correlazione. 105
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 105
L'instabilità affettiva nel Disturbo Borderline di Personalità e nella Ciclotimia. 104
“Effect of valproic acid on plasma concentrations of olanzapine in patients with psychiatric disorders” 103
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 103
Focus on Disruptive Mood Dysregulation Disorder: A review of the literature 103
Criminalità giovanile: correlati neuropsicologici e psicopatologici. 102
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 102
Totale 13.877
Categoria #
all - tutte 109.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021976 0 0 0 0 0 225 95 185 94 176 102 99
2021/20222.247 31 253 37 71 84 26 107 96 107 482 262 691
2022/20235.636 395 510 248 374 544 535 64 297 2.378 58 180 53
2023/20242.018 133 266 161 211 172 350 95 86 58 155 109 222
2024/20256.973 163 131 223 452 368 300 144 1.284 1.682 402 670 1.154
2025/20266.632 1.030 1.203 1.477 1.218 1.529 175 0 0 0 0 0 0
Totale 29.472